DexCom, Abbott Settle
The Wall Street Journal|December 26, 2024
DexCom and Abbott Diabetes Care entered a settlement and patent cross-license agreement, resolving all outstanding litigation between the two.
CONNOR HART
DexCom, Abbott Settle

Bu hikaye The Wall Street Journal dergisinin December 26, 2024 sayısından alınmıştır.

Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.

Bu hikaye The Wall Street Journal dergisinin December 26, 2024 sayısından alınmıştır.

Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.